PNC Financial Services Group
ANVS icon

PNC Financial Services Group’s Annovis Bio ANVS Stock Holding History

PNC Financial Services Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Hold
360
– – ﹤0.01% 4917
2026
Q1 		$803 Hold
360
– – ﹤0.01% 4806
2025
Q4 		$1.25K Hold
360
– – ﹤0.01% 4643
2025
Q3 		$745 Hold
360
– – ﹤0.01% 4732
2025
Q2 		$781 Hold
360
– – ﹤0.01% 4601
2025
Q1 		$540 Buy
+360
New +$1.1K ﹤0.01% 4628

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

PNC Financial Services Group's ANVS Position: Q2 2026 in Review

PNC Financial Services Group held its Annovis Bio (ANVS) position steady in Q2 2026 at 360 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #4917.

PNC Financial Services Group first reported a position in ANVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.25K in Q4 2025. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • PNC Financial Services Group held 360 shares of Annovis Bio worth $670 as of Q2 2026.
  • PNC Financial Services Group left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4917 holding.
  • PNC Financial Services Group first reported a position in Annovis Bio in Q1 2025 and has held it in 6 quarters since.
  • PNC Financial Services Group's Annovis Bio position peaked at $1.25K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.